Literature DB >> 28075045

Interplay Between Long Noncoding RNA ZEB1-AS1 and miR-200s Regulates Osteosarcoma Cell Proliferation and Migration.

Chibo Liu1, Chunqin Pan1, Yanqun Cai1, Haibao Wang2.   

Abstract

In our previous study, we found long noncoding RNA ZEB1-AS1 is upregulated and functions as an oncogene in osteosarcoma. MiR-200 family (miR-200s) functions as tumor suppressor via directly targeting ZEB1 in various cancers. In this study, we further investigate the potential interplay between ZEB1-AS1, miR-200s, and ZEB1 in osteosarcoma. Our results showed that ZEB1-AS1 functions as a molecular sponge for miR-200s and relieves the inhibition of ZEB1 caused by miR-200s. ZEB1-AS1 and miR-200s reciprocally negatively regulate each other. MiR-200s are downregulated in osteosarcoma tissues, and negatively correlated with ZEB1-AS1 and ZEB1 expression levels in osteosarcoma. Functional experiments showed that consistent with ZEB1-AS1 depletion, miR-200s overexpression and ZEB1 depletion both inhibit osteosarcoma cell proliferation and migration. Overexpression of miR-200s partially abolished the effects of ZEB1-AS1 on osteosarcoma cell proliferation and migration. Moreover, the combination of ZEB1-AS1 depletion and miR-200s overexpression significantly inhibits osteosarcoma cell proliferation and migration. In conclusion, this study revealed a novel regulatory mechanism between ZEB1-AS1, miR-200s, and ZEB1. The interplay between ZEB1-AS1 and miR-200s contributes to osteosarcoma cell proliferation and migration, and targeting this interplay could be a promising strategy for osteosarcoma treatment. J. Cell. Biochem. 118: 2250-2260, 2017.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  CELL MIGRATION; CELL PROLIFERATION; LONG NONCODING RNA; OSTEOSARCOMA; ZEB1-AS1; miR-200 FAMILY; microRNA

Mesh:

Substances:

Year:  2017        PMID: 28075045     DOI: 10.1002/jcb.25879

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  28 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation.

Authors:  Jin Gao; Yuan Yuan; Lili Zhang; Shaorong Yu; Jianwei Lu; Jifeng Feng; Sainan Hu
Journal:  Cancer Cell Int       Date:  2020-03-23       Impact factor: 5.722

3.  The lncRNA ZEB1-AS1 sponges miR-181a-5p to promote colorectal cancer cell proliferation by regulating Wnt/β-catenin signaling.

Authors:  Shao-Yan Lv; Ti-Dong Shan; Xin-Ting Pan; Zi-Bin Tian; Xi-Shuang Liu; Fu-Guo Liu; Xue-Guo Sun; Hui-Guang Xue; Xin-Hua Li; Yue Han; Li-Juan Sun; Li Chen; Ling-Yun Zhang
Journal:  Cell Cycle       Date:  2018-07-17       Impact factor: 4.534

Review 4.  ZEB1: New advances in fibrosis and cancer.

Authors:  Lin Cheng; Ming-Yuan Zhou; Ying-Jian Gu; Lei Chen; Yun Wang
Journal:  Mol Cell Biochem       Date:  2021-01-08       Impact factor: 3.396

Review 5.  ZEB1-AS1: A crucial cancer-related long non-coding RNA.

Authors:  Jinglin Li; Zhenglong Li; Kaiming Leng; Yi Xu; Daolin Ji; Lining Huang; Yunfu Cui; Xingming Jiang
Journal:  Cell Prolif       Date:  2017-12-10       Impact factor: 6.831

6.  Long noncoding RNA ZEB1-AS1 affects paclitaxel and cisplatin resistance by regulating MMP19 in epithelial ovarian cancer cells.

Authors:  Chencheng Dai; Pengfei Xu; Siyu Liu; Sujuan Xu; Juan Xu; Ziyi Fu; Jian Cao; Mingming Lv; Juan Zhou; Guangquan Liu; Huilin Zhang; Xuemei Jia
Journal:  Arch Gynecol Obstet       Date:  2020-11-05       Impact factor: 2.344

7.  Increased expression of lncRNA ZEB1-AS1 in non-small cell lung cancer is associated with poor prognosis.

Authors:  Jing Xie; Yufeng Wu; Xiaojie Bian; Dongqin Chen; Qi Gui; Jianan Huang
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

8.  Long noncoding RNA ZEB1-AS1 epigenetically regulates the expressions of ZEB1 and downstream molecules in prostate cancer.

Authors:  Wenjing Su; Miao Xu; Xueqin Chen; Ni Chen; Jing Gong; Ling Nie; Ling Li; Xinglan Li; Mengni Zhang; Qiao Zhou
Journal:  Mol Cancer       Date:  2017-08-23       Impact factor: 27.401

Review 9.  Oncogenic functions of ZEB1 in pediatric solid cancers: interplays with microRNAs and long noncoding RNAs.

Authors:  Lívia Fratini; Mariane Jaeger; Caroline Brunetto de Farias; André T Brunetto; Algemir L Brunetto; Lisa Shaw; Rafael Roesler
Journal:  Mol Cell Biochem       Date:  2021-07-22       Impact factor: 3.396

Review 10.  Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells.

Authors:  Richard Heery; Stephen P Finn; Sinead Cuffe; Steven G Gray
Journal:  Cancers (Basel)       Date:  2017-04-21       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.